
Also read | COVID-19: Ahead of mass vaccination drive, PM Modi set to discuss vaccine rollout plan with CMs
He also highlighted the rapid work that various industries did in India at the beginning of the pandemic to provide medical equipment that the country was lacking. He said that earlier, India used to have to import PPE kits, testing kits, masks as well as ventilators, but in the duration of the pandemic, the country became self-reliant. Now, the country is poised to save mankind with the help of two vaccines that have been made in India.
On January 3, Indian regulators approved two vaccines against the coronavirus pandemic for restricted use in emergency situations. One of them has been developed entirely in India. Covaxin has been developed by Bharat Biotech, which worked on this with the Indian Council of Medical Research (ICMR), the nodal health agency in India which spearheaded the fight against COVID-19 in the country. On the other hand, the second vaccine that has been approved is Covishield. Though being manufactured by Pune-based Serum Institute of India (SII), which is the largest manufacturer of vaccines in the world in terms of doses, the vaccine is a variant of the one developed by Oxford and AstraZeneca, as SII had formed an agreement with them and obtained a licence to manufacture as well as to conduct trials for it in India.
With the vaccinations having received regulatory approval, the vaccination drive in India is expected to commence this month itself.
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.